NYSE - Nasdaq Real Time Price USD

Koninklijke Philips N.V. (PHG)

Compare
26.51 -5.16 (-16.29%)
As of 3:17 pm GMT-4. Market open.
Advanced chart
Loading Chart for PHG
DELL
  • Previous close 31.67
  • Open 26.19
  • Bid 26.48 x 800
  • Ask 26.50 x 1000
  • Day's range 26.09 - 26.74
  • 52-week range 18.47 - 32.91
  • Volume 3,845,285
  • Avg. Volume 808,043
  • Market cap (intra-day) 24.971B
  • Beta (5Y monthly) 0.72
  • PE ratio (TTM) --
  • EPS (TTM) -0.63
  • Earnings date 28 Oct 2024
  • Forward dividend & yield --
  • Ex-dividend date 12 May 2022
  • 1y target est 29.79

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

www.philips.com

68,701

Full-time employees

31 December

Fiscal year ends

Healthcare

Sector

Medical Devices

Industry

More about Koninklijke Philips N.V.

Recent news: PHG

View more
View more

Related videos: PHG

AI is 'enhancing' healthcare staff, not replacing: Philips CEO

As AI becomes increasingly adopted in healthcare, Philips (PHG) CEO Roy Jakobs joins Morning Brief to discuss how the technology is revolutionizing the industry. Jakobs points to Philips's SmartSpeed algorithm as a way to increase the speed of its MRI machine imaging by three times. "We see 25% penetration of that algorithm on all the MRs (magnetic resonance imaging) that are in Japan from Philips. That's a significant uptake in a very short amount of time because it just doubles the productivity of that MR in the market," he tells Yahoo Finance. He argues that AI is supporting the healthcare industry, rather than replacing it amid staffing shortages tied to post-COVID rates of burnout. "So actually, we cannot get enough people to step into the practice," Jakobs explains. "We are supporting the doctors with better tools to do diagnosis faster, to do minimally invasive therapies, or actually to monitor patients in a more predictive manner." Jakobs adds that this all helps in cutting down the workload for medical technicians and other staff: "And we're helping the nurses so that actually we can expand, for example, the ratio of how many patients they can watch after in an ICU from 1 to 7 by the use of a tele-ICU application. So distinct needs areas where actually this is enhancing the staff currently, not replacing them." To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Melanie Riehl
Yahoo Finance Video · 2 hr ago
RYLPF
+11.89%
PHG
-16.29%

Performance overview: PHG

Trailing total returns as of 28/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD return

PHG
13.63%
AEX-Index
13.98%

1-year return

PHG
43.30%
AEX-Index
25.56%

3-year return

PHG
41.38%
AEX-Index
10.00%

5-year return

PHG
36.10%
AEX-Index
53.61%

Compare to: PHG

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

PHG
Koninklijke Philips N.V.
26.51
-16.29%
Mkt cap 24.971B
Industry Medical Devices
PRCT
PROCEPT BioRobotics Corporation
88.90
+29.27%
Mkt cap 4.617B
Industry Medical Devices
MASI
Masimo Corporation
140.64
+0.94%
Mkt cap 7.664B
Industry Medical Devices
SNN
Smith & Nephew plc
28.82
+1.59%
Mkt cap 12.914B
Industry Medical Devices
EW
Edwards Lifesciences Corporation
68.43
-1.37%
Mkt cap 41.953B
Industry Medical Devices
BSX
Boston Scientific Corporation
84.90
+0.19%
Mkt cap 129.032B
Industry Medical Devices
MDT
Medtronic plc
90.78
+0.20%
Mkt cap 118.588B
Industry Medical Devices
SYK
Stryker Corporation
355.56
+0.78%
Mkt cap 139.495B
Industry Medical Devices
PODD
Insulet Corporation
234.11
+0.21%
Mkt cap 16.5B
Industry Medical Devices
STE
STERIS plc
223.99
-0.06%
Mkt cap 22.089B
Industry Medical Devices
ZBH
Zimmer Biomet Holdings, Inc.
103.83
+1.45%
Mkt cap 21.631B
Industry Medical Devices

Statistics: PHG

View more

Valuation measures

As of 25/10/2024

  • Market cap

    29.73B

  • Enterprise value

    36.72B

  • Trailing P/E

    --

  • Forward P/E

    15.70

  • PEG ratio (5-yr expected)

    0.38

  • Price/sales (ttm)

    1.59

  • Price/book (mrq)

    2.30

  • Enterprise value/revenue

    1.87

  • Enterprise value/EBITDA

    24.37

Financial highlights

Profitability and income statement

  • Profit margin

    -2.32%

  • Return on assets (ttm)

    1.36%

  • Return on equity (ttm)

    -4.59%

  • Revenue (ttm)

    18.13B

  • Net income avi to common (ttm)

    -555M

  • Diluted EPS (ttm)

    -0.63

Balance sheet and cash flow

  • Total cash (mrq)

    1.81B

  • Total debt/equity (mrq)

    69.35%

  • Levered free cash flow (ttm)

    1.85B

View more

Research analysis: PHG

View more

Earnings per share

Consensus EPS
 

Revenue vs. Earnings

Revenue 4.46B
Earnings 451M
 

Analyst recommendations

  • Strong buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analysts' price targets

18.74 Low
29.79 Average
26.51 Current
36.57 High
 
View more

People also watch

STM STMicroelectronics N.V.
28.52
+1.05%
 
UL Unilever PLC
62.53
+1.35%
 
ING ING Groep N.V.
17.04
+1.16%
 
SNY Sanofi
54.57
+0.42%
 
SNN Smith & Nephew plc
28.82
+1.59%
 
NVS Novartis AG
115.60
+1.59%
 
DEO Diageo plc
133.75
+0.36%
 
TEF Telefónica, S.A.
4.6600
+0.87%
 
ROK Rockwell Automation, Inc.
272.04
+0.81%
 
FMS Fresenius Medical Care AG
20.88
-0.26%
 
RMD ResMed Inc.
247.96
-3.17%
 
SAP SAP SE
240.77
+1.30%
 
PH Parker-Hannifin Corporation
625.91
+0.67%
 
E Eni S.p.A.
30.50
-1.61%
 
BAX Baxter International Inc.
36.08
+0.29%
 
PKX POSCO Holdings Inc.
62.57
+4.24%